Characterization of the mTOR autophosphorylation site, S2481, as a novel biomarker in renal cell carcinoma (RCC).
Lauren Christine Harshman
Consultant or Advisory Role - Theragene (U)
Karra Muller
No relevant relationships to disclose
Chii-Dean Lin
No relevant relationships to disclose
James D. Brooks
No relevant relationships to disclose
John Higgins
No relevant relationships to disclose
Jon Berglin
Employment or Leadership Position - Theragene
Stock Ownership - Theragene
Research Funding - Theragene
Tony Hunter
Consultant or Advisory Role - Theragene
Stock Ownership - Theragene
Jeremy Copp
Employment or Leadership Position - Theragene
Stock Ownership - Theragene